Russia’s Sputnik V vaccine 91.6% effective against COVID-19 in late-stage trial: study

Russia’s Sputnik V vaccine 91.6% effective against COVID-19 in late-stage trial: study

Russia’s Sputnik V vaccine was 91.6% effective against COVID-19 disease in a late-stage trial, according to new interim results. The results come in stark contrast to the consensus among U.S. health officials, including Dr. Anthony Fauci, who sowed serious doubt over the jab after it was rolled out in Russia ahead of advanced studies on safety and efficacy.